|
|
| Line 3: |
Line 3: |
| | <StructureSection load='6s0y' size='340' side='right'caption='[[6s0y]], [[Resolution|resolution]] 1.81Å' scene=''> | | <StructureSection load='6s0y' size='340' side='right'caption='[[6s0y]], [[Resolution|resolution]] 1.81Å' scene=''> |
| | == Structural highlights == | | == Structural highlights == |
| - | <table><tr><td colspan='2'>[[6s0y]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6S0Y OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6S0Y FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6s0y]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Influenza_A_virus_(A/Jeju/2279/2007(H1N1)) Influenza A virus (A/Jeju/2279/2007(H1N1))] and [https://en.wikipedia.org/wiki/Lama_glama Lama glama]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6S0Y OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6S0Y FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6s0y FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6s0y OCA], [http://pdbe.org/6s0y PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6s0y RCSB], [http://www.ebi.ac.uk/pdbsum/6s0y PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6s0y ProSAT]</span></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.81Å</td></tr> |
| | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6s0y FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6s0y OCA], [https://pdbe.org/6s0y PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6s0y RCSB], [https://www.ebi.ac.uk/pdbsum/6s0y PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6s0y ProSAT]</span></td></tr> |
| | </table> | | </table> |
| | == Function == | | == Function == |
| - | [[http://www.uniprot.org/uniprot/B2VLW8_9INFA B2VLW8_9INFA]] Forms a proton-selective ion channel that is necessary for the efficient release of the viral genome during virus entry.[RuleBase:RU361247] | + | [https://www.uniprot.org/uniprot/B2VLW8_9INFA B2VLW8_9INFA] Forms a proton-selective ion channel that is necessary for the efficient release of the viral genome during virus entry.[RuleBase:RU361247] |
| | <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| | == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
| Line 17: |
Line 18: |
| | </div> | | </div> |
| | <div class="pdbe-citations 6s0y" style="background-color:#fffaf0;"></div> | | <div class="pdbe-citations 6s0y" style="background-color:#fffaf0;"></div> |
| | + | |
| | + | ==See Also== |
| | + | *[[Antibody 3D structures|Antibody 3D structures]] |
| | == References == | | == References == |
| | <references/> | | <references/> |
| | __TOC__ | | __TOC__ |
| | </StructureSection> | | </StructureSection> |
| | + | [[Category: Lama glama]] |
| | [[Category: Large Structures]] | | [[Category: Large Structures]] |
| - | [[Category: Molle, I Van]] | + | [[Category: De Vlieger D]] |
| - | [[Category: Remaut, H]] | + | [[Category: Remaut H]] |
| - | [[Category: Saelens, X]] | + | [[Category: Saelens X]] |
| - | [[Category: Schepens, B]] | + | [[Category: Schepens B]] |
| - | [[Category: Vlieger, D De]] | + | [[Category: Van Molle I]] |
| - | [[Category: Antiviral protein]]
| + | |
| - | [[Category: Fc gamma receptor iv]]
| + | |
| - | [[Category: Influenza some]]
| + | |
| - | [[Category: M2 matrix protein]]
| + | |
| - | [[Category: Nanobody]]
| + | |
| Structural highlights
Function
B2VLW8_9INFA Forms a proton-selective ion channel that is necessary for the efficient release of the viral genome during virus entry.[RuleBase:RU361247]
Publication Abstract from PubMed
Lower respiratory tract infections, such as infections caused by influenza A viruses, are a constant threat for public health. Antivirals are indispensable to control disease caused by epidemic as well as pandemic influenza A. We developed a novel anti-influenza A virus approach based on an engineered single-domain antibody (VHH) construct that can selectively recruit innate immune cells to the sites of virus replication. This protective construct comprises two VHHs. One VHH binds with nanomolar affinity to the conserved influenza A matrix protein 2 (M2) ectodomain (M2e). Co-crystal structure analysis revealed that the complementarity determining regions 2 and 3 of this VHH embrace M2e. The second selected VHH specifically binds to the mouse Fcgamma Receptor IV (FcgammaRIV) and was genetically fused to the M2e-specific VHH, which resulted in a bi-specific VHH-based construct that could be efficiently expressed in Pichia pastoris. In the presence of M2 expressing or influenza A virus-infected target cells, this single domain antibody construct selectively activated the mouse FcgammaRIV. Moreover, intranasal delivery of this bispecific FcgammaRIV-engaging VHH construct protected wild type but not FcgammaRIV (-/-) mice against challenge with an H3N2 influenza virus. These results provide proof of concept that VHHs directed against a surface exposed viral antigen can be readily armed with effector functions that trigger protective antiviral activity beyond direct virus neutralization.
Selective Engagement of FcgammaRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection.,De Vlieger D, Hoffmann K, Van Molle I, Nerinckx W, Van Hoecke L, Ballegeer M, Creytens S, Remaut H, Hengel H, Schepens B, Saelens X Front Immunol. 2019 Dec 12;10:2920. doi: 10.3389/fimmu.2019.02920. eCollection, 2019. PMID:31921179[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ De Vlieger D, Hoffmann K, Van Molle I, Nerinckx W, Van Hoecke L, Ballegeer M, Creytens S, Remaut H, Hengel H, Schepens B, Saelens X. Selective Engagement of FcgammaRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection. Front Immunol. 2019 Dec 12;10:2920. doi: 10.3389/fimmu.2019.02920. eCollection, 2019. PMID:31921179 doi:http://dx.doi.org/10.3389/fimmu.2019.02920
|
